carvedilol has been researched along with Complication, Postoperative in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Aim was to evaluate the efficacy of metoprolol, carvedilol, and carvedilol plus NAC on the prevention of post-operative atrial fibrillation (POAF)." | 9.17 | Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study. ( Akcay, S; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, O; Varol, E; Yucel, H, 2013) |
| "Although all beta blockers appear to be effective in the prevention of postoperative atrial fibrillation (AF) following coronary artery bypass surgery (CABG), carvedilol was found to be much more effective than metoprolol in this respect as the current study clearly delineated." | 7.75 | Beta blockers for the prevention of atrial fibrillation after coronary artery bypass surgery: carvedilol versus metoprolol. ( Celik, M; Celik, T; Gunay, C; Isik, E; Iyisoy, A; Jata, B, 2009) |
| " The purpose of the present case cohort study compared the control group with no carvedilol administered and the other group of patients given carvedilol and determined whether postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting (CABG)." | 7.74 | Postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting. ( Izumoto, H; Kawazoe, K; Okabayashi, H; Tsuboi, J, 2008) |
| "Metoprolol was started at 50 mg twice daily and carvedilol was started at 12." | 6.73 | Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery. ( Acikel, S; Aydinalp, A; Bal, U; Bozbas, H; Gultekin, B; Muderrisoglu, H; Ozin, B; Saritas, B; Sezgin, A; Yildirir, A, 2008) |
| "The carvedilol group was treated with mean daily dose of 46 +/- 9 mg and metoprolol group with mean daily dose of 93 +/- 11 mg." | 6.73 | Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol. ( Alizadeh, A; Emkanjoo, Z; Fazelifar, AF; Ghafarinejad, MH; Givtaj, N; Haghjoo, M; Hashemi, MJ; Hosseini, S; Khamoushi, AJ; Sadr-Ameli, MA; Saravi, M, 2007) |
| "Carvedilol is a non-selective β-adrenergic blocker with anti-inflammatory, antioxidant, and multiple cationic channel blocking properties." | 6.50 | Carvedilol for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. ( Wang, HS; Wang, ZW; Yin, ZT, 2014) |
| " Aim was to evaluate the efficacy of metoprolol, carvedilol, and carvedilol plus NAC on the prevention of post-operative atrial fibrillation (POAF)." | 5.17 | Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study. ( Akcay, S; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, O; Varol, E; Yucel, H, 2013) |
| " In addition, factors potentially involved in hepatic ischemia-reperfusion injury, including oxidative stress (malondialdehyde and superoxide anion levels), mitochondrial damage (glutamate dehydrogenase activity), microcirculatory disorders (flow rate and vascular resistance), and adenosine triphosphate (ATP) depletion, were evaluated after reperfusion." | 3.76 | Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation. ( Alfany-Fernandez, I; Ben Abdennebi, H; Ben Mosbah, I; Boillot, O; Lojek, A; Mitjavila, MT; Parellada, PP; Peralta, C; Rimola, A; Rodés, J; Roselló-Catafau, J, 2010) |
| "Although all beta blockers appear to be effective in the prevention of postoperative atrial fibrillation (AF) following coronary artery bypass surgery (CABG), carvedilol was found to be much more effective than metoprolol in this respect as the current study clearly delineated." | 3.75 | Beta blockers for the prevention of atrial fibrillation after coronary artery bypass surgery: carvedilol versus metoprolol. ( Celik, M; Celik, T; Gunay, C; Isik, E; Iyisoy, A; Jata, B, 2009) |
| " The purpose of the present case cohort study compared the control group with no carvedilol administered and the other group of patients given carvedilol and determined whether postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting (CABG)." | 3.74 | Postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting. ( Izumoto, H; Kawazoe, K; Okabayashi, H; Tsuboi, J, 2008) |
| "Metoprolol was started at 50 mg twice daily and carvedilol was started at 12." | 2.73 | Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery. ( Acikel, S; Aydinalp, A; Bal, U; Bozbas, H; Gultekin, B; Muderrisoglu, H; Ozin, B; Saritas, B; Sezgin, A; Yildirir, A, 2008) |
| "The carvedilol group was treated with mean daily dose of 46 +/- 9 mg and metoprolol group with mean daily dose of 93 +/- 11 mg." | 2.73 | Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol. ( Alizadeh, A; Emkanjoo, Z; Fazelifar, AF; Ghafarinejad, MH; Givtaj, N; Haghjoo, M; Hashemi, MJ; Hosseini, S; Khamoushi, AJ; Sadr-Ameli, MA; Saravi, M, 2007) |
| "Carvedilol is a non-selective β-adrenergic blocker with anti-inflammatory, antioxidant, and multiple cationic channel blocking properties." | 2.50 | Carvedilol for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. ( Wang, HS; Wang, ZW; Yin, ZT, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Stone, KH | 1 |
| Reynolds, K | 1 |
| Davis, S | 1 |
| Van Tassell, BW | 1 |
| Gibson, CM | 1 |
| Jalalian, R | 1 |
| Maleki, M | 1 |
| Ghafari, R | 1 |
| Habibi, V | 1 |
| Heydari, S | 1 |
| Iranian, M | 1 |
| Wang, HS | 1 |
| Wang, ZW | 1 |
| Yin, ZT | 1 |
| Ben Mosbah, I | 1 |
| Roselló-Catafau, J | 1 |
| Alfany-Fernandez, I | 1 |
| Rimola, A | 1 |
| Parellada, PP | 1 |
| Mitjavila, MT | 1 |
| Lojek, A | 1 |
| Ben Abdennebi, H | 1 |
| Boillot, O | 1 |
| Rodés, J | 1 |
| Peralta, C | 1 |
| Ozaydin, M | 1 |
| Icli, A | 1 |
| Yucel, H | 1 |
| Akcay, S | 1 |
| Peker, O | 1 |
| Erdogan, D | 1 |
| Varol, E | 1 |
| Dogan, A | 1 |
| Okutan, H | 1 |
| Calò, L | 1 |
| Giacon, B | 1 |
| Davis, PA | 1 |
| Pagnin, E | 1 |
| Piccin, A | 1 |
| Riegler, P | 1 |
| Huber, W | 1 |
| Antonello, A | 1 |
| Semplicini, A | 1 |
| Merritt, JC | 1 |
| Niebauer, M | 1 |
| Tarakji, K | 1 |
| Hammer, D | 1 |
| Mills, RM | 1 |
| Serón, D | 1 |
| Acikel, S | 1 |
| Bozbas, H | 1 |
| Gultekin, B | 1 |
| Aydinalp, A | 1 |
| Saritas, B | 1 |
| Bal, U | 1 |
| Yildirir, A | 1 |
| Muderrisoglu, H | 1 |
| Sezgin, A | 1 |
| Ozin, B | 1 |
| Haghjoo, M | 1 |
| Saravi, M | 1 |
| Hashemi, MJ | 1 |
| Hosseini, S | 1 |
| Givtaj, N | 1 |
| Ghafarinejad, MH | 1 |
| Khamoushi, AJ | 1 |
| Emkanjoo, Z | 1 |
| Fazelifar, AF | 1 |
| Alizadeh, A | 1 |
| Sadr-Ameli, MA | 1 |
| Celik, T | 1 |
| Iyisoy, A | 1 |
| Jata, B | 1 |
| Celik, M | 1 |
| Gunay, C | 1 |
| Isik, E | 1 |
| Katritsis, DG | 1 |
| Tsuboi, J | 1 |
| Kawazoe, K | 1 |
| Izumoto, H | 1 |
| Okabayashi, H | 1 |
1 review available for carvedilol and Complication, Postoperative
| Article | Year |
|---|---|
Carvedilol for prevention of atrial fibrillation after cardiac surgery: a meta-analysis.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Carbazoles; Cardiac Surgical Procedures; Carvedilo | 2014 |
5 trials available for carvedilol and Complication, Postoperative
| Article | Year |
|---|---|
Comparing the efficacy of N-acetylcysteine plus carvedilol versus carvedilol in the prevention of atrial fibrillation following coronary artery bypass graft surgery.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Atrial Fibrillation; Carvedilol; Coronary Artery Bypass | 2022 |
Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study.
Topics: Acetylcysteine; Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Carb | 2013 |
Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Calcium Channel Blocker | 2002 |
Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Carbazoles; Carved | 2008 |
Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Carbazoles; Carvedilol | 2007 |
7 other studies available for carvedilol and Complication, Postoperative
| Article | Year |
|---|---|
Comparison of new-onset post-operative atrial fibrillation between patients receiving carvedilol and metoprolol after off-pump coronary artery bypass graft surgery.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Bradycardia; Carvedilol; Coronary Artery By | 2023 |
Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.
Topics: Adenosine; Adenosine Triphosphate; Adenylate Kinase; Adrenergic beta-Antagonists; Allopurinol; Anima | 2010 |
Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Carbazoles; Carvedilol; Coronary | 2003 |
Management of cardiovascular risk in patients receiving calcineurin inhibitors--a case report.
Topics: Acenocoumarol; Amiodarone; Angioplasty; Calcineurin Inhibitors; Carbazoles; Carvedilol; Cyclosporine | 2006 |
Beta blockers for the prevention of atrial fibrillation after coronary artery bypass surgery: carvedilol versus metoprolol.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Carbazoles; Carvedilol; Coronary Artery Bypass; Hu | 2009 |
Carvedilol is more effective than metoprolol in preventing atrial fibrillation (AF) after coronary artery bypass.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Carbazoles; Carvedilol | 2008 |
Postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Carbazoles; Carvedilol; Case-Control Studies | 2008 |